SOX2 and squamous cancers-Reference-Cited by-同舟云学术

SOX2 and squamous cancers

Published:2020-12 Issue: Volume:67 Page:154-167
ISSN:1044-579X
Container-title:Seminars in Cancer Biology
language:en
Short-container-title:Seminars in Cancer Biology

Author:

Porter Linsey,McCaughan Frank

Funder

Wellcome Trust and by Wellcome Trust Intermediate Clinical Fellowship

Roy Castle Lung Cancer Foundation

National Centre for the Replacement Refinement

Reduction of Animals in Research

NIHR Cambridge Biomedical Research Centre

NIHR or the Department of Health and Social Care

Publisher

Elsevier BV

Subject

Cancer Research

Reference159 articles.

1. 3q26 Amplification and polysomy of chromosome 3 in squamous cell lesions of the lung: a fluorescence in situ hybridization study;Pelosi;Clin. Cancer Res.,2007

2. Gain of chromosome 3q is an early and consistent genetic aberration in carcinomas of the vulva;Stoltzfus;Int. J. Gynecol. Cancer,2005

3. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas;Singh;Am. J. Pathol.,2002

4. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers;Yokoi;Clin. Cancer Res.,2003

5. Copy number changes of target genes in chromosome 3q25.3-qter of esophageal squamous cell carcinoma: TP63 is amplified in early carcinogenesis but down-regulated as disease progressed;Yen;World J. Gastroenterol.,2005

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Skin Development and Disease: A Molecular Perspective;Current Issues in Molecular Biology;2024-07-30

2. Jmjd2c maintains the ALDH ^bri+ cancer stemness with transcription factor SOX2 in lung squamous cell carcinoma;Cancer Biology & Therapy;2024-07-08

3. Non-coding RNAs as therapeutic targets in cancer and its clinical application;Journal of Pharmaceutical Analysis;2024-07

4. An analysis of the influencing factors of false negative autoantibodies in patients with non-small cell lung cancer;Frontiers in Oncology;2024-05-10

5. Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 degradation;Cell & Bioscience;2024-03-17